Rheumatology New Patient Consultation Note
A comprehensive rheumatology new patient consultation template structured around the referral question, outside record synthesis, targeted autoimmune history and exam, and problem-oriented assessment and plan. Emphasizes…
Document Type
clinical note / Consultation Note
Specialties
Template Preview
Date: [Date of encounter]
Location: [Clinic location / facility]
Clinician: [Clinician name, credentials]
Visit Type: Rheumatology – New Patient Consultation
Referral Source: [Referring clinician, organization]
Referral Question: [Specific question or condition to evaluate]
Primary Historian: [Historian(s) and reliability statement]
Allergies: [Drug allergies and reaction types, or "NKDA"]
Chief Complaint
[Primary reason for consultation] (One line; include brief clarifying patient quote if helpful.)
Outside Records Reviewed
(List sources with date ranges. If none available, state: "No outside records available at time of visit.")
- [Source, record type, date range]
- [Source, record type, date range]
Synthesis:
- [Key trends or patterns relevant to today's decisions]
- [Discordance between reported and documented findings, if present]
- [Prior treatments, response, and tolerability]
- [Pertinent prior diagnoses with supporting data]
- [Other high-yield findings]
Gaps: [Missing records and plan to obtain] (Omit line if not applicable.)
History of Present Illness
[Narrative HPI] (Include: onset and evolution with first symptom date or best estimate; anatomic pattern with joints/regions and symmetry; inflammatory features including morning stiffness duration, nocturnal pain, swelling, response to NSAIDs/steroids; associated systemic symptoms if relevant; functional impact on ADLs, work, sleep; prior evaluation and treatments with response and adverse effects; contextual triggers or exposures. Add targeted rheumatology features per referral question: prior autoimmune diagnoses and serologies; thrombosis/pregnancy history if APS suspected; sicca symptoms for Sjögren's; Raynaud's pattern for scleroderma spectrum; proximal weakness for myositis; psoriasis/IBD for spondyloarthritis.)
Autoimmune Review of Systems
(Include positives and discriminating negatives only. Omit domains not assessed or not relevant.)
- Constitutional: [Fever, weight change, fatigue]
- Eyes: [Redness, dryness, vision changes]
- Oral/ENT: [Dry mouth, ulcers, salivary swelling]
- Skin/Hair/Nails: [Photosensitivity, rash, psoriasis, nail changes, alopecia, digital ulcers]
- Vascular: [Raynaud's characteristics and triggers]
- Cardiopulmonary: [Pleuritic pain, dyspnea, cough]
- GI: [Dysphagia, abdominal pain, IBD features]
- Renal: [Foamy urine, hematuria, edema]
- Neurologic: [Headaches, neuropathy symptoms]
- MSK: [Joint swelling, enthesitis, dactylitis, inflammatory back pain]
- Hematologic/OB: [Cytopenias, miscarriages, thrombosis]
Past Medical & Surgical History
- [Prior rheumatologic or autoimmune diagnoses]
- [Malignancy history and treatment status]
- [Chronic infections: HBV, HCV, HIV, TB]
- [Hepatic or renal disease]
- [History of recurrent or serious infections]
- [Relevant surgeries]
Medications
Current medications:
- [Medication – dose, route, frequency; adherence notes if relevant]
Prior anti-inflammatory and immunomodulatory therapy:
- [Agent – dates – response – adverse effects – reason stopped]
Family History
- [Inflammatory arthritis or connective tissue disease]
- [Psoriasis or IBD]
- [Gout]
- [Thrombosis or pregnancy losses]
- [Other autoimmune conditions]
Social History
- [Occupation; functional/disability status]
- [Tobacco and alcohol use with treatment implications]
- [Relevant exposures: travel, ticks, TB risk factors]
- [Reproductive considerations if relevant to treatment planning]
Physical Examination
Vitals: [BP, HR, RR, Temp, SpO2, weight]
General: [Appearance, level of distress]
Skin: [Lesion morphology and distribution; psoriasis locations; nail findings; scleroderma-spectrum signs if relevant]
Musculoskeletal: [Focused / Comprehensive] joint exam performed. [Tender and swollen joints by region; warmth, effusion; ROM limitations; deformities; synovitis vs bony enlargement; grip strength; gait. Include axial exam, enthesitis sites, and dactylitis assessment if spondyloarthritis suspected.]
Neurologic: [Strength, sensation, reflexes; proximal muscle strength if myositis suspected]
Other systems: [Eyes/ENT, cardiopulmonary, extremities/vascular findings as indicated]
(State explicitly if any portion was limited or not performed.)
Results Reviewed Today
- [Key laboratory data with dates – highlight abnormal and discriminating normal results]
- [Imaging findings]
- [Pathology if applicable]
- [Disease activity measures if obtained]
Assessment
[Summary statement: patient demographics, key comorbidities, core symptom pattern and duration, salient exam findings, most discriminating labs/imaging, and the referral question]
[Problem 1: Diagnosis or symptom-based label]
- Evidence for: [Supporting features]
- Evidence against: [Contradictory findings or alternative explanations]
- Differential: [Ranked realistic options; note "can't miss" entities]
- Uncertainty: [What is missing to confirm/exclude diagnosis]
(If autoantibodies present without supportive clinical features, explicitly state insufficient evidence for diagnosis.)
[Problem 2: Diagnosis or symptom-based label]
- Evidence for: [Supporting features]
- Evidence against: [Contradictory findings]
- Differential: [Ranked options]
- Uncertainty: [Missing information]
Plan
(Organize by problem: severity/urgency first, then patient priorities, then preventive/safety items.)
[Problem 1]: Plan
- Diagnostic: [Tests to order; how results will change management; plan for missing data]
- Therapeutic: [Nonpharmacologic measures; medication changes with doses and taper strategies]
- Monitoring: [Lab schedule tied to therapies; infection risk counseling if immunosuppression]
- Coordination: [Communication with referring clinician; co-management needs]
- Return precautions: [Red-flag symptoms warranting earlier contact]
[Problem 2]: Plan
- Diagnostic: [Tests and rationale]
- Therapeutic: [Treatment plan]
- Monitoring: [Monitoring plan]
- Coordination: [Care coordination]
- Return precautions: [Warning signs]
Immunosuppression pre-treatment checklist (Include if initiating or considering immunosuppressive therapy):
- Vaccinations: [Status; plan for indicated vaccines and timing relative to therapy]
- Infection screening: [TB, hepatitis B/C, HIV as indicated; results or tests ordered]
- Baseline labs: [Required for chosen therapy]
- Reproductive health: [Pregnancy intention; contraception; teratogenic risk counseling]
- Bone health: [Calcium/vitamin D; bisphosphonate consideration; DEXA status] (If glucocorticoids planned.)
Follow-up
Follow-up interval: [Timeframe and modality]
Pending results: [What is pending; communication plan for results]
Referrals placed: [Specialty, reason, urgency]
Consult report: [Sent to / will be sent to] referring clinician.
(Omit sections not relevant or not performed. For high-impact missing information affecting safety—pregnancy status before teratogenic therapy, infection screening before biologics, uncertain medication history—insert explicit placeholder indicating unknown/pending status and plan to obtain. Maintain source attribution for information from outside records or non-patient historians.)
Want to use this template?
Copy it into your workflow, or book a demo to see Augustun draft notes like this automatically.